EASL Campus

Anonymous created an event

4 months ago
Anonymous created an event

6 months ago
Anonymous created an event

7 months ago
Anonymous created an event

7 months ago
Anonymous created an event

8 months ago
Anonymous created an event

9 months ago
Anonymous created an event

9 months ago
Anonymous created an event

9 months ago
Anonymous created an event

9 months ago
Anonymous created an event

9 months ago
Christian Molina-Aguilar posted

10 months ago
Margaret Vernon commented on EASL Studio - Deciphering the dr…

10 months ago

EASL Studio - Deciphering the drivers of cirrhosis decompensation: Opportunities for intervention and prevention (Complete Session)

EASL Studio - Deciphering the drivers of cirrhosis decompensation: Opportunities for intervention and prevention   Debbie Shawcross (Moderator), Paolo Angeli (Faculty), Salvador Augustin (Boehringer Ingelheim representative), Paolo Caraceni (CSL Behring representative) This EASL Studio is supported by Boehr...

0

2

Read more about EASL Studio - Deciphering the drivers of cirrhosis decompensation: Opportunities for intervention and prevention (Complete Session)
Log in to post comments

Margaret Vernon • 10 months ago

Excellent discussion - very informative - thank you

Reply

Comment

Margaret Vernon • 10 months ago

Excellent discussion - very informative - thank you

Reply

Comment
Anonymous created an event

11 months ago
Luis Rodriguez commented on TIPS and ascites (Complete Sessi…

11 months ago
Anonymous created an event

1 year ago
ABU SALEH MD SADEQUL ISLAM commented on Non-alcoholic fatty liver diseas…

1 year ago

Non-alcoholic fatty liver disease: A patient guideline

This patient guideline is intended for all patients at risk of or living with non-alcoholic fatty liver disease (NAFLD). NAFLD is the most frequent chronic liver disease worldwide and comes with a high disease burden. Yet, there is a lot of unawareness. Furthermore, many aspects of the disease are still to be unravelled, which ha...

2

1

ABU SALEH MD S… • 1 year ago

EASY LANGUAGE

Reply

Comment
ABU SALEH MD SADEQUL ISLAM commented on Liver Cancer Explained

1 year ago

Liver Cancer Explained

Liver cancer is the third leading cause of cancer-related deaths worldwide and the primary cause of death for patients with cirrhosis. Most of liver cancers are hepatocellular carcinomas, however some patients develop intrahepatic cholangiocarcinomas (ICC) or rare tumours in non-cirrhotic livers. Chronic liver diseases, alcohol c...

1

1

ABU SALEH MD S… • 1 year ago

EXCELLENT SUMMARIZE

Reply

Comment
Anonymous created an event

1 year ago
ABU SALEH MD SADEQUL ISLAM commented on ILC 2021 Takeaways – Public heal…

1 year ago

ILC 2021 Takeaways – Public health

As part of the International Liver Congress (ILC) 2021, the EASL Takeaways take a look at key topics from the congress, with leading experts discussing the most impactful science and putting it into perspective. This session, presented by Professors Maria Buti, Shira Zelber-Sagi and Antonio Craxì, explores prominent themes f...

1

1

Read more about ILC 2021 Takeaways – Public health
Log in to post comments

ABU SALEH MD S… • 1 year ago

EXCELLENT DISCUSSION

Reply

Comment
元春刘 posted

1 year ago

EASL Studio - Deciphering the drivers of cirrhosis decompensation: Opportunities for intervention and prevention (Complete Session)

Non-alcoholic fatty liver disease: A patient guideline

Liver Cancer Explained

ILC 2021 Takeaways – Public health